ICOS Corporation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ICOS Corporation

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: SemiBull who wrote (871)	1/23/2002 9:47:02 AM
From: tuck	Read Replies (1) of 1139

>>INDIANAPOLIS--(BW HealthWire)--Jan. 23, 2002--Lilly ICOS LLC today announced that the UK Court of Appeal in London upheld a lower court's ruling that found Pfizer's entire ``method of use'' patent for PDE inhibitors to treat erectile dysfunction (ED) was invalid. This decision follows a December 2001 hearing in which Pfizer attempted to reinstate its method of use patent that was struck down by the High Court of Justice in London on November 8, 2000. Lilly ICOS offered the following statement regarding the decision: Lilly ICOS is pleased with the Court of Appeal's decision. This ruling confirms what we have believed all along -- that Pfizer's broad method of use patent was invalid. This decision makes it clear that Pfizer is not entitled to exclusivity in the field of ED in the UK. This decision is consistent with the decision of the Opposition Division of the European Patent Office which ruled last summer that Pfizer's method of use patent was invalid. This decision leaves unaffected Pfizer's compound patent for sildenafil. Lilly ICOS is investigating Cialis(TM) (tadalafil) for the treatment of sexual dysfunction. Requests for marketing approval of Cialis are currently under review by US and European regulatory agencies. Lilly ICOS LLC is a joint venture between ICOS Corporation (Nasdaq:ICOS - news) and Eli Lilly and Company (NYSE:LLY - news). Eli Lilly and Company, a leading innovation-driven corporation, is developing a growing portfolio of best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers -- through medicines and information -- for some of the world's most urgent medical needs.<< snip Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next